Design and synthesis of pyridine-substituted itraconazole analogues with improved antifungal activities, water solubility and bioavailability.

[1]  C. Girmenia.  New generation azole antifungals in clinical investigation , 2009, Expert opinion on investigational drugs.

[2]  J. Chodakewitz,et al.  Advances in antifungal therapy. , 2008, Annual review of medicine.

[3]  J. Meis,et al.  Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2005: an 8.5-Year Analysis of Susceptibilities of Candida Species and Other Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion Testing , 2007, Journal of Clinical Microbiology.

[4]  Ronald N. Jones,et al.  International Surveillance of Candida spp. and Aspergillus spp.: Report from the SENTRY Antimicrobial Surveillance Program (2003) , 2006, Journal of Clinical Microbiology.

[5]  D. Loebenberg,et al.  Hydroxylated analogues of the orally active broad spectrum antifungal, Sch 51048 (1), and the discovery of posaconazole [Sch 56592; 2 or (S,S)-5]. , 2006, Bioorganic & medicinal chemistry letters.

[6]  Qi Gao,et al.  Phosphonooxymethyl prodrugs of the broad spectrum antifungal azole, ravuconazole: synthesis and biological properties. , 2003, Bioorganic & medicinal chemistry letters.

[7]  M. Hepperle,et al.  Mono N-arylation of piperazine(III): metal-catalyzed N-arylation and its application to the novel preparations of the antifungal posaconazole and its advanced intermediate , 2002 .

[8]  T J Walsh,et al.  Antifungal agents: chemotherapeutic targets and immunologic strategies , 1996, Antimicrobial agents and chemotherapy.

[9]  J. Heeres,et al.  Antimycotic azoles. 7. Synthesis and antifungal properties of a series of novel triazol-3-ones. , 1984, Journal of medicinal chemistry.